Psoriasis
Blue and Red Light Equal at Treating Psoriasis, Blue Better at Reducing Redness
Randomized Controlled Trial J Eur Acad Dermatol Venereol . 2012 Feb;26(2):219-25. doi: 10.1111/j.1468-3083.2011.04039.x. Epub 2011 Mar 24. Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study M M Kleinpenning 1, M E Otero, P E J van Erp, M J P Gerritsen, P C M van de … Read more
633 nm and 830 nm Psoriasis LED Therapy Regimen
Nine psoriasis patients used 633 nm red and 830 nm infrared LED therapy on recalcitrant psoriasis. The majority had failed earlier treatments.
Seven patients show 60% to 100% clearance of psoriasis symptoms when measured from three to 8 months after treatment. Two of the subjects could not be located.
Physician’s Office Psoralen UVA and UVB for Psoriasis
Researchers treated 25 psoriasis patients with psoralen and ultraviolet-A (PUVA), and another 25 patients with psoralent and ultraviolet-B (PUVB). Psoriasis affected 25-70% of the patient’s skin. After 8 weeks of treatment, 92% of the PUVA group, and 80% of the PUVB group had remission. Limbs and trunk were more resistant than the rest of the body. 28% of PUVA and 24% of PUVB suffered erythema (redness); 32% and 28% pruitis (itchiness); 28% and 24% nausea and vomiting; 16% and 12% fever & malaise; 12% and 16% headache; 1% and 0% blister; 1% and 0% claustrophobia. Researchers concluded that PUVA and PUVB had substantially similar positive outcomes.
Narrow Band Ultraviolet B (NB-UVB) Psoriasis Treatment (Not a Home Treatment)
Physician’s office treatment (not a home therapy) using Narrow Band Ultraviolet B (NB-UVB) for psoriasis patients affected on greater than 10% of the body and have not responded to other treatments. UVB is dangerous without safety precautions. The doctor uses an excimer laser. The patient is treated 2x-3x per week. Is potentially combined with “emollients, calcipotriene, cortico-steroids, retinoids, and tar. NB-UVB can be used in selected patients with traditional systemic agents such as methotrexate, mycophenolate mofetil, and cyclosporine…”